Zealand Pharma is a biotechnology company based in Denmark that designs and develops peptide-based medicines. Its work centres on metabolic and gastrointestinal diseases, with products that include a treatment for severe low blood sugar in people with diabetes and a therapy for short bowel syndrome. The company also has earlier-stage programmes in areas such as obesity and other metabolic conditions, and it works with partners on some of its candidates.
The shares are listed on the Copenhagen Exchange in Denmark under the code ZEAL, and the price on this page is in Danish kroner (DKK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #145 of 164 on the Copenhagen Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Denmark yet.
TrendWeak
7/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-26.6%
From 52-week high-57.6%
MomentumWeak
7/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-21.1%
6-month return-24.4%
12-month, skipping last month-38.5%
Stability (higher is calmer)Weak
8/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)71.7%
Worst drawdown, 1 year (smaller is calmer)-59.4%
LiquidityStrong
92/100
Trades actively.
See the numbers →
Avg daily value traded111.22M DKK
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Denmark when fundamentals data for this market is added. All Denmark stocks.
52-wk range 220.60 – 556.00Daily closes, split-adjusted
Signals
50-day average277.46
200-day average315.37
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)9.78
Technical summary
Daily
Strongly bearish
1 bullish · 4 neutral · 11 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
230.2
Bullish
EMA 10
233.5
Bearish
SMA 20
245.3
Bearish
EMA 20
244.1
Bearish
SMA 50
277.5
Bearish
EMA 50
266.9
Bearish
SMA 100
287.9
Bearish
EMA 100
286.7
Bearish
SMA 200
315.4
Bearish
EMA 200
322.7
Bearish
Oscillators (daily)
RSI (14)
33.68
Neutral
MACD (12, 26)
-14.64
Bearish
Momentum (12)
-7.85
Bearish
Stochastic %K (14)
21.39
Neutral
Williams %R (14)
-78.61
Neutral
CCI (20)
-62.69
Neutral
Pivot points (classic, last session)
S3
222.3
S2
224.9
S1
228.2
Pivot
230.8
R1
234.1
R2
236.7
R3
240.0
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in DKK. Educational only, not financial advice.
